MYCN and neuroblastoma: Different parameters have been used to classify patients with neuroblastoma into subgroups by their risk of death: age at diagnosis, metastatic spread, degree of tumor differentiation as well as histological features, mitosis-index, MYCN oncogene amplification, 1p/17q/11q status, DNA ploidy and LDH and ferritin levels [3,4].